Clincosm LogoSign in Get a demo

stage ivb salivary gland cancer

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +57 more
  • placebo
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 18, 2020

Mucositis, Oral Complications, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Trial in United States (acetylcysteine, ,

Completed
Has Results
  • Mucositis
  • +82 more
  • Scottsdale, Arizona
  • +4 more
Apr 22, 2019

Recurrent Salivary Gland Cancer, Stage IVA Salivary Gland Cancer, Stage IVB Salivary Gland Cancer Trial in Seattle (eribulin

Completed
Has Results
  • Recurrent Salivary Gland Cancer
  • +3 more
  • eribulin mesylate
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 30, 2018

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +36 more
  • sorafenib tosylate
  • +3 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
May 22, 2018

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Terminated
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +45 more
  • talactoferrin
  • laboratory biomarker analysis
  • Stanford, California
    Stanford University
Jul 30, 2016

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 17, 2014

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +33 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Feb 26, 2013

Anaplastic Thyroid Cancer, Insular Thyroid Cancer, Metastatic Parathyroid Cancer Trial in San Antonio (gefitinib)

Completed
  • Anaplastic Thyroid Cancer
  • +85 more
  • San Antonio, Texas
    Southwest Oncology Group
Jan 11, 2013

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Colon Cancer Trial

Completed
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +48 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 6, 2012